Different Clinical Outcomes in Crohn’s Disease Patients With Esophagogastroduodenal, Jejunal, and Proximal Ileal Disease Involvement: Is L4 Truly a Single Phenotype?

Therapeutic Advances in Gastroenterology - United Kingdom
doi 10.1177/1756284818777938
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Crohn’s Disease Presenting as Ileo-Ileal Intussusception: A Case Report

Surgery: Current Research
2012English

Early Anti-TNF/Immunomodulator Therapy Is Associated With Better Long-Term Clinical Outcomes in Asian Patients With Crohn’s Disease With Poor Prognostic Factors

PLoS ONE
Multidisciplinary
2017English

Correlation of Biomarker Expression in Colonic Mucosa With Disease Phenotype in Crohn’s Disease and Ulcerative Colitis

Digestive Diseases and Sciences
PhysiologyGastroenterology
2015English

Serum Anti-Glycan Antibodies in Paediatric-Onset Crohn’s Disease: Association With Disease Phenotype and Diagnostic Accuracy

Przeglad Gastroenterologiczny
Gastroenterology
2014English

Clinical and Pharmacokinetic Factors Associated With Adalimumab-Induced Mucosal Healing in Patients With Crohn’s Disease

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2018English

Inflammation Drives Dysbiosis and Bacterial Invasion in Murine Models of Ileal Crohn’s Disease

PLoS ONE
Multidisciplinary
2012English

A Prospective Study Comparing Patient-Reported Outcomes in Crohn’s Disease

European Journal of Gastroenterology and Hepatology
HepatologyGastroenterology
2020English

Infliximab Versus Adalimumab in Patients With Biologic-Naïve Crohn’s Disease: Is the Difference Real?

Digestive Diseases and Sciences
PhysiologyGastroenterology
2018English

Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease

Gastroenterology
HepatologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy